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Making the Case for Public Health: 
Estimating ROI and Value 
 
Glen Mays, PhD, MPH  
University of Kentucky 
ASTHO Senior Deputies Meeting  •  Boston, MA   •  18 July 2012 
Why ROI? 
Do outcomes achieved by public health 
interventions justify their costs? 
Where should new investments be directed 
to achieve their greatest impact? 
Related questions of value… 
• How much health can we produce through 
public health investments? 
• Can public health investments help “bend the 
curve” to contain medical costs? 
ROI Uncertainty and Controversy 
Public health spending and medical costs 
per case 
Roehrig et al. Health Affairs 2011 
Challenges in demonstrating ROI  
in public health 
Time lag between costs and benefits 
Distribution of costs and benefits: 
concentrated costs but diffuse benefits 
Measurement of costs and benefits requires 
good information systems 
• Attribution of benefits: the counterfactual 
ROI Key Ingredients  
Investments 
Costs of implementing public health interventions 
Who’s investments? 
Returns 
Valuation of the outputs and outcomes attributable 
to public health interventions 
Who realizes returns? 
Over what time frames? 
Compared to what?  
Managing ROI Expectations 
Cost savings – a high bar 
Cost effectiveness – value for dollars spent 
– Compared to status quo 
– Compared to other possible investments 
– Compared to doing nothing 
 
…Key concept: opportunity costs 
Estimating ROI in public health:  
Key Considerations 
Perspective 
Federal, state, health system, or societal? 
Time Horizon 
How long can you wait to realize returns? 
Types of Interventions 
Primary, secondary or tertiary prevention 
Cross-cutting infrastructure 
 
Estimating ROI in public health:  
Key Considerations - Costs 
Direct costs 
Cost of implementing intervention/infrastructure 
Cost savings attributable to the intervention 
Indirect costs 
Economic value of productivity gains/losses or time 
savings/costs attributable to the intervention 
 
Estimating ROI in public health:  
Key Considerations - Benefits 
Efficiency gains (captured in cost measures) 
Reduced labor costs 
Reduced material costs 
Productivity gains (captured in output measures) 
Services delivered 
Cases detected 
Revenue gains (captured in financial measures) 
Health gains (captured in outcome measures) 
Deaths averted 
Cases prevented 
Quality-adjusted life years gained 
 
Estimating ROI in public health:  
Key Considerations 
Break even 
How long does it take to recoup investment? 
Maintenance/Persistence 
How long do the benefits last?  
Recurring costs? 
Achieving ROI in public health:  
Key Considerations 
Economies of scale: many public health 
interventions can be delivered more efficiently 
across larger populations 
Economies of scope: efficiencies can be realized by 
using the same infrastructure to deliver an array of 
related programs and services 
 
Estimating ROI in public health:  
Types of Analyses 
Macro-level analysis 
Infrastructure-level analysis 
Intervention-level analysis 
Process-level analysis 
Estimating ROI in public health:  
Macro-level Analysis 
Source: Trust for America’s Health, 2009 
Estimating ROI in public health:  
Intervention-level Analysis 
• Smoking cessation interventions cost an estimated 
$2,587 for each life-year gained 
• $1 spent on STD and pregnancy prevention 
produces $2.65 in medical cost savings  
• $1 spent on preconception care for diabetic women 
produces $5.19 in medical cost savings 
• $1 spent on childhood  
immunization produces  
$6.30 in medical cost savings 
 
Source: Centers for Disease Control and Prevention 2008 
Mortality reductions attributable to local 
public health spending, 1993-2008 
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Mays et al. Health Affairs, 2011 
Medical Care Offsets Attributable to  
Local Public Health Spending, 1993-2008 
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Mays et al. Health Services Research, 2009 
Medical Cost Offset = 0.088% 
Projected effects of new 
ACA public health spending 
• 1.2% increase in public health spending in 
average community over 10 years: 
 
Public health cost   $7.2M 
Medical cost offset     -$6.3M  (Medicare only) 
Deaths averted          175.8 
Life years gained        1758 
Net cost/LY           $546 
 
Mays et al. forthcoming 2012 
Preventable disease burden  
and national health spending 
>75% of national health spending is attributable 
to chronic diseases that are largely preventable 
– 80% of cardiovascular disease 
– 80% of diabetes 
– 60% of lung diseases 
– 40% of cancers 
(not counting injuries, vaccine-preventable diseases) 
<3% of national health spending is allocated to 
public health and prevention 
CDC 2011 
Public health’s share of national health spending 
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Public Health in the Affordable Care Act 
 Public Health & Prevention Fund: $15 billion in 
new federal public health spending over 10 
years (cut by $5B this year) 
 Incentives for hospitals, health insurers, 
employers to invest in public health and 
prevention 
 
Implications for Policy and Practice 
 Mortality reductions achievable through 
increases in public health spending may equal or 
exceed the reductions produced by similar 
expansions in local medical care resources 
 Increased public health investments help to 
reduce geographic disparities in population 
health and bend the medical cost curve   
 Gains from increased federal investments may 
be offset by reductions in state and local 
spending   
 
Advancing ROI Analysis  
in Public Health 
 Enhanced tracking of public health expenditures 
 Enhanced monitoring of program performance 
– Reach/targeting 
– Effectiveness 
– Efficiency 
– Equity 
 Analysis of cross-cutting infrastructure needed to 
implement/maintain programs 
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